177 related articles for article (PubMed ID: 27871302)
1. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF
Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302
[TBL] [Abstract][Full Text] [Related]
2. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study.
Qurashi I; Chu S; Drake R; Hartley V; Chaudhry I; Deakin JFW; Husain N
Pilot Feasibility Stud; 2019; 5():79. PubMed ID: 31236286
[TBL] [Abstract][Full Text] [Related]
3. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
Trials; 2014 Feb; 15():60. PubMed ID: 24533890
[TBL] [Abstract][Full Text] [Related]
4. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
Segev A; Evans A; Hodsoll J; Whiskey E; Sheriff RS; Shergill S; MacCabe JH
Int Clin Psychopharmacol; 2019 Mar; 34(2):101-107. PubMed ID: 30614850
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
6. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
Mubaslat O; Lambert T
Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
[TBL] [Abstract][Full Text] [Related]
7. Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.
Kreinin A; Miodownik C; Mirkin V; Gaiduk Y; Yankovsky Y; Bersudsky Y; Lerner PP; Bergman J; Lerner V
J Clin Psychopharmacol; 2016 Jun; 36(3):200-5. PubMed ID: 27028980
[TBL] [Abstract][Full Text] [Related]
8. Trihexyphenidyl treatment of clozapine-induced hypersalivation.
Spivak B; Adlersberg S; Rosen L; Gonen N; Mester R; Weizman A
Int Clin Psychopharmacol; 1997 Jul; 12(4):213-5. PubMed ID: 9347382
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
Man WH; Colen-de Koning JC; Schulte PF; Cahn W; van Haelst IM; Doodeman HJ; Egberts TC; Heerdink ER; Wilting I
J Clin Psychopharmacol; 2017 Apr; 37(2):155-161. PubMed ID: 28129312
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
Takeuchi I; Hanya M; Uno J; Fujita K; Kamei H
Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study.
Bai YM; Lin CC; Chen JY; Liu WC
J Clin Psychopharmacol; 2001 Dec; 21(6):608-11. PubMed ID: 11763010
[TBL] [Abstract][Full Text] [Related]
12. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
[TBL] [Abstract][Full Text] [Related]
13. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
Kreinin A; Novitski D; Weizman A
Int Clin Psychopharmacol; 2006 Mar; 21(2):99-103. PubMed ID: 16421461
[TBL] [Abstract][Full Text] [Related]
14. Low-dose glycopyrrolate for clozapine-associated sialorrhea.
Praharaj SK; Munoli RN; Sharma PS
J Clin Psychopharmacol; 2014 Jun; 34(3):392. PubMed ID: 24717248
[No Abstract] [Full Text] [Related]
15. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
Blissit KT; Tillery E; Latham C; Pacheco-Perez J
Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
[TBL] [Abstract][Full Text] [Related]
16. Treatment effects of traditional Chinese medicines Suoquan Pill and Wuling Powder on clozapine-induced hypersalivation in patients with schizophrenia: study protocol of a randomized, placebo-controlled trial.
Hung CC; Fu PK; Wang HY; Chan CH; Lan TH
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):495-502. PubMed ID: 21565135
[TBL] [Abstract][Full Text] [Related]
17. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
Calderon J; Rubin E; Sobota WL
Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287
[TBL] [Abstract][Full Text] [Related]
18. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N
J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092
[TBL] [Abstract][Full Text] [Related]
19. Glycopyrrolate for clozapine-induced sialorrhea.
Duggal HS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1546-7. PubMed ID: 17614181
[No Abstract] [Full Text] [Related]
20. Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia.
Essali A; Rihawi A; Altujjar M; Alhafez B; Tarboush A; Alhaj Hasan N
Cochrane Database Syst Rev; 2013 Dec; (12):CD009546. PubMed ID: 24353163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
